Category: News

Post

Cathance Fitness Center Reopening

The Cathance Fitness Center will be reopening on May 2nd, 2022 with a new improved website with the feature of…

Post

Exciting Announcement from FHC and NeuraLynx

Dear Neuralynx and FHC Customers, Users, Distributors, Industry Partners, and Colleagues, We are pleased to announce the merger of our…

Post

FHC Launches New STarFix Direct Website

FHC is excited to announce the launch of our new STarFix Direct website, offering a new robust and user-friendly way…

Post

FHC Has Reopened

Following implementation of pre-screening measures and continuing attention to social distancing, FHC’s global headquarters in Bowdoin, ME and STarFix Platform…

Post

FHC’s Coronavirus Update

FHC’s global headquarters in Bowdoin, Maine and STarFix Platform production facility in Greenville, PA are currently operating on a limited…

Post

Our Response to Coronavirus

As the outbreak of coronavirus (COVID-19) continues to evolve, FHC has increased our level of awareness and are working to…

Post

Regional Sales Managers, Northeast, Midwest and Southwest Regions

The Regional Sales Manager (RSM),  is accountable for daily sales, design and implementation/execution of tactical plans for the FHC products…

Post

Clinical Application and Sales Specialists, Northeast, Midwest, Southwest and Western regions

The Clinical Applications and Sales Specialist (CASS),  is responsible for all aspects of Procedural and Technical Support and will also…

Post

FHC Partners with Neurotargeting to Offer New Solution for Epilepsy Treatment

BOWDOIN, ME – FHC, Inc. and Neurotargeting, LLC have released WayPoint™ Navigator 4.5 planning software, now allowing epileptologists, neurosurgeons, and…

Post

FHC Announces Comprehensive Epilepsy Solutions for Neurosurgery

BOWDOIN, ME – According to the American Epilepsy Society, at least 30-40% of individuals don’t respond to current antiepileptic drugs,…

Popup Image